TC BIOPHARM HOLDINGS PLC (TCBPXXXX)
Institutional ownership reported to the SEC as of Q3 2023, across 4 quarters.
9
Reporting holders
$174.6K
Reported value
0.0%
Held as options
+5
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Modera Wealth Management, LLC | $466.0K | 16,244 | 0.01% | new | NEW |
| ARMISTICE CAPITAL, LLC | $127.9K | 297,500 | 0.00% | 4q | -43.7%-$99.2K |
| Csenge Advisory Group | $11.2K | 26,000 | 0.00% | new | NEW |
| Cresset Asset Management, LLC | $10.8K | 25,000 | 0.00% | new | NEW |
| TWO SIGMA SECURITIES, LLC | $5.8K | 13,401 | 0.00% | new | NEW |
| XTX Topco Ltd | $5.7K | 13,617 | 0.00% | new | NEW |
| CITADEL ADVISORS LLC | $5.7K | 13,543 | 0.00% | 2q | -82.0%-$25.8K |
| WELLS FARGO & COMPANY/MN | $5.6K | 13,000 | 0.00% | 3q | HELD |
| UBS Group AG | $1.5K | 3,516 | 0.00% | 2q | +13.4% |
| CLEAR STREET LLC | $569 | 1,323 | 0.00% | new | NEW |
| RENAISSANCE TECHNOLOGIES LLC | $5 | 11,003 | 0.00% | 2q | -84.7% |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q3 2023 | 9 | $174.6K | 406,900 | 5 | 1 | 2 | 0.0% |
| Q2 2023 | 4 | $335.1K | 619,708 | 2 | 2 | 0 | 0.0% |
| Q1 2023 | 4 | $204.3K | 129,704 | 3 | 1 | 0 | 0.0% |
| Q4 2022 | 2 | $323.8K | 84,104 | 2 | 0 | 0 | 0.0% |